Do you want to read an article? Please log in or register.
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
Lung, Respiratory and Thoracic Cancer
RECOMMENDED
Related content
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
★ 1
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
★ 3
Recommended by
Dr Martin Frey, Faculty Member
N Engl J Med
Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, Falchook GS, Price TJ, Sacher A, Denlinger CS, Bang YJ, Dy GK, Krauss JC, Kuboki Y, Kuo JC, Coveler AL, Park K, Kim TW, Barlesi F, Munster PN, Ramalingam SS, Burns TF, Meric-Bernstam F, Henary H, Ngang J, Ngarmchamnanrith G, Kim J, Houk BE, Canon J, Lipford JR, Friberg G, Lito P, Govindan R, Li BT
doi: 10.1056/NEJMoa1917239
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Breast CancerGenitourinary Cancer
The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review
Cancer Treat Rev.
de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR
doi: 10.1016/j.ctrv.2017.10.010.
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Sebastian M, Eberhardt WEE, Hoffknecht P, Metzenmacher M, Wehler T, Kokowski K, Alt J, Schütte W, Büttner R, Heukamp LC, Stenzinger A, Jänicke M, Fleitz A, Zacharias S, Dille S, Hipper A, Sandberg M, Weichert W, Groschek M, von der Heyde E, Rauh J, Dechow T, Thomas M, Griesinger F, CRISP Registry Group.
doi: 10.1016/j.lungcan.2021.02.005
SPECIAL REPORT
Multiple Myeloma (MM)
Therapie des rezidivierten/refraktären Multiplen Myeloms
SPECIAL REPORT
Multiple Myeloma (MM)
Traitement du myélome multiple récidivant/réfractaire
Lung, Respiratory and Thoracic Cancer
HER2 mediates clinical resistance to the KRASG12C inhibitor sotorasib, which is overcome by co-targeting SHP2
Eur J Cancer
Ho CSL, Tüns AI, Schildhaus HU, Wiesweg M, Grüner BM, Hegedus B, Schuler M, Schramm A, Oeck S
doi: 10.1016/j.ejca.2021.10.003
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R
doi: 10.1056/NEJMoa2103695
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Sotorasib for Lung Cancers with KRAS p.G12C Mutation
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Wolf-Dieter Janthur, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
N Engl J Med
Skoulidis F, Li BT, Dy GK, Price TJ, Falchook GS, Wolf J, Italiano A, Schuler M, Borghaei H, Barlesi F, Kato T, Curioni-Fontecedro A, Sacher A, Spira A, Ramalingam SS, Takahashi T, Besse B, Anderson A, Ang A, Tran Q, Mather O, Henary H, Ngarmchamnanrith G, Friberg G, Velcheti V, Govindan R
doi: 10.1056/NEJMoa2103695